Treatment Trials

5 Clinical Trials for Various Conditions

Focus your search

      ENROLLING_BY_INVITATION
      A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
      Description

      This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer's disease. Up to approximately 670 subjects will be randomized to 12 months of daily treatment with either Active or Sham Sensory Stimulation Systems. Efficacy will be measured using the Alzheimer's Disease Cooperative Study- Activities of Daily Living (ADCS-ADL) assessment and a combined statistical test (CST) of the ADCS-ADL and the Mini-Mental State Exam (MMSE).

      Conditions
      Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2Alzheimer Disease 3Alzheimer Disease, Early OnsetAlzheimer Disease, Late OnsetAlzheimer Disease 9Alzheimer Disease 4Alzheimer Disease 7Alzheimer Disease 17Alzheimer's Dementia Late OnsetAlzheimer Disease 5Alzheimer Disease 6Alzheimer Disease 8Alzheimer Disease 10Alzheimer Disease 11Alzheimer Disease 12Alzheimer Disease 13Alzheimer Disease 14Alzheimer Disease 15Alzheimer Disease 16Alzheimer Disease 18Alzheimer Disease 19DementiaDementia AlzheimersDementia, MildDementia of Alzheimer TypeDementia ModerateDementia SenileMild Cognitive ImpairmentMild DementiaMCICognitive ImpairmentCognitive DeclineCognitive Impairment, Mild
      Talk to us
      WITHDRAWN
      A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
      Description

      This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Alzheimer's disease.

      Conditions
      Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2Alzheimer Disease 3Alzheimer Disease 4Alzheimer Disease 5Alzheimer Disease 6Alzheimer Disease 7Alzheimer Disease 8Alzheimer Disease 9, Late-OnsetAlzheimer Disease 10Alzheimer Disease 11Alzheimer Disease 12Alzheimer Disease 13Alzheimer Disease 14Alzheimer Disease 15Alzheimer Disease 16Alzheimer Disease 17Alzheimer Disease 18Alzheimer Disease 19Alzheimer Disease, Early OnsetAlzheimer Disease, Late OnsetAlzheimer Disease Focal
      Talk to us
      COMPLETED
      A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
      Description

      The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer's Disease.

      Conditions
      Alzheimer's DiseaseDementia
      Talk to us
      COMPLETED
      Development of NIC5-15 in the Treatment of Alzheimer's Disease
      Description

      The purpose of this study is to evaluate the safety and efficacy of NIC5-15in the treatment of Alzheimer's Disease.

      Conditions
      Alzheimer DiseaseDementia
      Talk to us
      COMPLETED
      Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
      Description

      The purpose of this study was to support the optimal use of rivastigmine patch in long-term treatment of Alzheimer's Disease in patients demonstrating functional and cognitive decline at the target maintenance dose of rivastigmine patch 10 cm\^2.

      Conditions
      Alzheimer Disease
      Talk to us